Atance R et al., 2001-12: Retrospective hospital study in Barcelona finding that switching to methylene blue-photoinactivated plasma (which loses fibrinogen and factors V and VIII) increased plasma and cryoprecipitate consumption by more than half.
The use of PIP was associated with a 56-percent incre
Abstract
Atance R et al., 2001-12: Retrospective hospital study in Barcelona finding that switching to methylene blue-photoinactivated plasma (which loses fibrinogen and factors V and VIII) increased plasma and cryoprecipitate consumption by more than half. Study type: retrospective before-and-after analysis of hospital transfusion use over three 1-year periods; 2,967 patients, 27,434 plasma units, Hospital Clínic Barcelona, Spain. Comparator: historical period using untreated FFP. Result: 56% increase in plasma use associated with PIP. Funding/COI not stated in retrieved abstract record. Note the quoted sentence is cut at the point the abstract truncates in the record ('56-percent incre…'); the complete figure is 56 percent as stated in the same sentence.
